Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuren Pharmaceuticals Limited has requested an immediate trading halt of its securities on the ASX, citing an impending announcement about the Phase 2 clinical trial results for Pitt Hopkins syndrome. The trading halt will remain in effect until the announcement is made or trading resumes on Monday, 27 May 2024. This strategic pause is anticipated to maintain market order until significant company news is disclosed.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.